UNC Eshelman School of Pharmacy
||A major contributor to this article appears to have a close connection with its subject. (November 2010)|
|UNC Eshelman School of Pharmacy|
|University of North Carolina
at Chapel Hill
|Location||Chapel Hill, North Carolina, with a branch campus in Asheville|
|Dean||Robert Blouin, PharmD|
|Website||UNC Eshelman School of Pharmacy|
The UNC Eshelman School of Pharmacy is located at the University of North Carolina at Chapel Hill. The school's doctor of pharmacy program was ranked second among pharmacy schools in the United States in 2012 by the U.S. News & World Report. The school was founded in 1897 and is one of the oldest schools of pharmacy in the nation. It is accredited by the American Council for Pharmacy Education and is a member of the American Association of Colleges of Pharmacy. The School educates approximately 550 professional students and 100 graduate students, postdocs, residents, and fellows each year. Robert A. Blouin is the current dean.
Academic Degree Programs
The UNC Eshelman School of Pharmacy offers three academic degrees:
- Doctor of pharmacy (PharmD): A professional degree for people interested in becoming pharmacists. The PharmD is similar to the doctor of medicine (MD) for physicians or a doctor of dental surgery (DDS) for dentists. The PharmD program is a four-year program, preceded by at least two years of prerequisite coursework, with the majority of students holding a previously earned degree (Bachelor's, Master's, or other professional). In 2011, the school began offering a five-year PharmD/MBA dual-degree program in conjunction with the Kenan-Flagler Business School.
- PhD in Pharmaceutical Sciences: A graduate program that prepares students for careers in pharmaceutical research. The school’s PhD students choose one of four concentrations, each of which corresponds to a stage in the drug-development cycle:
- Chemical Biology and Medicinal Chemistry
- Molecular Pharmaceutics
- Pharmacotherapy and Experimental Therapeutics
- Pharmaceutical Outcomes and Policy
- MS in Health System Pharmacy: The master of science in health system pharmacy prepares pharmacists for leadership positions in health care. It combines classroom instruction with a two-year residency in a health-system setting.
The UNC Eshelman School of Pharmacy offers postgraduate training through fellowships and residencies. The school also provides continuing education programs for practicing pharmacists.
- Fellowships: The school’s Division of Pharmacotherapy and Experimental Therapeutics offers several industry-sponsored postdoctoral fellowships, including opportunities in clinical research and drug development, as well as fellowship programs in pharmacokinetics/pharmacodynamics. Academic fellowships in HIV, oncology, and heart failure are also available.
- Community pharmacy residencies: The school offers PGY1 and PGY2 residencies in community pharmacy. The school’s PGY1 community pharmacy residency program was established in 2000 and is one of the oldest accredited programs of its kind in the country. Residents are assigned to one of the partner pharmacies around North Carolina, where they work with their preceptors to initiate new programs and expand and enhance existing services. The school’s PGY2 residency was established in 2009 and was the first PGY2 community pharmacy residency in the country. The program focuses on preparing community pharmacy resident for future faculty positions by providing advanced training and experiences in clinical community practice and in a school-of-pharmacy setting.
- Hospital residencies: The school offers hospital pharmacy residencies through UNC Hospitals. The hospital’s pharmacy residency program began in 1967 and has trained more than 250 individuals. The program includes PGY1 and PGY2 residencies. The residents’ teaching experience is provided through the school, while the practice component is conducted by the hospital’s department of pharmacy.
- Continuing Education: The school’s Postgraduate/Continuing Education Program partners with the nine regional Area Health Education Centers and the North Carolina Association of Pharmacists to provide continuing education for the state’s pharmacists. The school complies with the Accreditation Council For Pharmacy Education’s (ACPE) Criteria for Quality for continuing education programming.
The UNC Eshelman School of Pharmacy’s research funding has increased steadily in recent years. In 2004, the school was seventeenth among the nation’s schools of pharmacy with $5.2 million of funding from the National Institutes of Health and fifteenth with $6.6 million of total federal funding. By 2009, the school had risen to second in NIH funding with $22.9 million and fourth in total federal funding with $24.9 million. 
In 2007, alumnus Fred Eshelman, CEO and founder of the contract-research company PPD Inc., pledged $9 million to support cancer research at the school. The board of North Carolina’s University Cancer Research Fund matched the gift, resulting in a total of $18 million. The funds are being used to support the work of members of the school and the UNC Lineberger Comprehensive Cancer Center who focus on genetics, individualized cancer therapy, drug discovery, and drug delivery. In December of 2014, Dr. Eshelman made a $100 million gift, the largest private donation the university has ever received, larger than any donation to a pharmacy school in history.
The school aligns its research with the four phases of the drug development and discovery cycle, each of which is represented by a division within the school:
- Discovery: Represented by the Division of Medicinal Chemistry and Natural Products, which focuses on finding new therapeutic agents and targets.
- Optimization: Represented by the Division of Molecular Pharmaceutics, which seeks to narrow the thousands of new and possibly therapeutic agents discovered in the first stage down to only the most successful compounds and therapies.
- Assessment: Represented by the Division of Pharmacotherapy and Experimental Therapeutics, which, in conjunction with UNC and Duke hospitals, takes the therapeutic agents to humans by focusing on three phases of clinical assessment and evaluation of drug targets: safety, efficacy, and the impact on specialized populations.
- Outcomes: Represented by the Division of Pharmaceutical Outcomes and Policy, which studies the effectiveness of delivery, patient compliance, and impact among specialized populations by focusing on the economic and health outcomes of therapies and pharmaceutical policies.
The school also has formed three research centers: The Institute for Pharmacogenomics and Individualized Therapy, the Center for Integrative Chemical Biology and Drug Discovery, and the Center for Nanotechnology in Drug Delivery.
Research at the school has spawned a number of spin-off companies:
- Arcato Labs
- Capture Pharmaceuticals
- Asklepios BioPharmaceutical Inc.
- Oriel Therapeutics (acquired by Sandoz)
- Cirrus Pharmaceuticals, Inc.
Students in the doctor of pharmacy program at the UNC Eshelman School of Pharmacy are based at one of two campuses in North Carolina: Chapel Hill and Asheville. Students can indicate their campus preference when submitting their application for the program, and the school decides the campus assignments. The curriculum and the admission and progression requirements are the same for students at both campuses. The school uses video-conferencing technology to deliver real-time, interactive classroom instruction from faculty at Chapel Hill to students at Asheville. Students at Asheville also receive assistance from faculty based at their respective branch campus. Students remain at their assigned campus for their first three years in the program and then spend their fourth year at a number of practice sites around the state.
- Chapel Hill: Students at this campus are based at the University of North Carolina at Chapel Hill, where the school is located. The Chapel Hill campus enrolls approximately 140 students in the UNC PharmD program each year.
- Asheville: In 2010, the UNC Eshelman School of Pharmacy received permission from the UNC Board of Governors to expand the school’s doctor of pharmacy program to Asheville, North Carolina, in an effort to address the pharmacist shortage in the western part of the state by educating more pharmacists in the region. The Asheville branch campus welcomed its first class of twenty to twenty-five students in fall 2011, with plans to enroll up to forty students in the future. The students in Asheville will graduate with a doctor of pharmacy from UNC-Chapel Hill.
From 1897 to 1912, the school was located on the ground floor of New West on the campus of the University of North Carolina at Chapel Hill. It relocated to Person hall in 1912 and then to Howell Hall in 1925. The school moved into its present location, Beard Hall, in 1959 and currently occupies three buildings on the UNC-Chapel Hill campus:
- Beard Hall: This building has been the home of the school since opening in 1959. It is named after John Grover Beard, the second dean of the School of Pharmacy. It completed a $6 million renovation in 2007.
- Kerr Hall: Named for school alumnus Banks D. Kerr, the founder of the Kerr Drug chain, this 65,000-square-foot (6,000 m2), $18.2 million annex to Beard Hall was dedicated in October 2002 and doubled the school’s facilities.
- Genetic Medicine Building: This 300,000-square-foot (28,000 m2) research facility was completed in 2008. The UNC Eshelman School of Pharmacy and the UNC School of Medicine share the building, with the pharmacy school occupying approximately 75,000 square feet (7,000 m2) of laboratory space on the first and second floors.
- Center for Integrative Chemical Biology and Drug Discovery: The CICBDD brings dedicated medicinal chemistry expertise to bear on biological targets of therapeutic relevance under investigation by UNC faculty.
- Center for Nanotechnology in Drug Delivery: The CNDD, part of a campus-wide nanomedicine initiative at UNC, brings together scientists to create nano-scale pharmaceutical innovations for therapeutic and diagnostic purposes.
- Institute for Pharmacogenomics and Individualized Therapy: The institute brings together researchers and clinicians across the University to create personalized therapies and treatments for patients suffering from a wide variety of conditions.
- Center for Educational Excellence in Pharmacy: The Center for Educational Excellence in Pharmacy is devoted to helping faculty provide their students with high-quality learning opportunities by improving the practice, scholarship, and research in evidence-based education.
Rankings and Reputation
- Ranked second among the nation’s doctor of pharmacy programs in U.S. News & World Report magazine’s 2008 edition of America’s Best Graduate Schools
- Received nearly $25 million in total research funding in 2009, according to AACP data
- Received nearly $23 million in funding from the National Institutes of Health and other federal sources in 2009, ranking second among the nation’s pharmacy schools in that area
The school was established in March 1897 in response to urgent requests of the pharmacists of the state and on the recommendations of university administration. Edward Vernon Howell, a pharmacist from Rocky Mount, North Carolina, was appointed professor and dean of the school. The school’s first class of 1897 had seventeen students and one instructor.
On May 21, 2008, the school’s name was changed from the UNC School of Pharmacy to the UNC Eshelman School of Pharmacy in honor of Fred Eshelman, CEO and founder of the contract-research company PPD Inc and a 1972 graduate of the school.
List of Deans
1897-1931: Edward Vernon Howell
1931-1946: John Grover Beard
1946-1950: Marion Lee Jacobs
1950-1966: Edward Armond Brecht
1966-1974: George Philip Hager, Jr.
1974-1975: Seymour Morton Blaug
1975-1977: Leroy Delbert Werley, Jr. (acting dean)
1977-1992: Tom Saburo Miya
1992-2003: William Howard Campbell
2003–present: Robert Alan Blouin